Literature DB >> 3168592

Aspergillus terreus as a cause of invasive pulmonary aspergillosis.

C K Moore1, M A Hellreich, C L Coblentz, V L Roggli.   

Abstract

A 70-year-old woman with nodular, poorly differentiated lymphocytic lymphoma is the third reported patient with invasive pulmonary aspergillosis caused by Aspergillus terreus. This case differs from the two previously reported in that neither neutropenia nor broad spectrum antibiotics preceded the infection. A terreus should not be dismissed as a laboratory contaminant in pulmonary specimens, especially those from immunosuppressed patients.

Entities:  

Mesh:

Year:  1988        PMID: 3168592     DOI: 10.1378/chest.94.4.889

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

3.  The Cu,Zn superoxide dismutases of Aspergillus flavus, Aspergillus niger, Aspergillus nidulans, and Aspergillus terreus: purification and biochemical comparison with the Aspergillus fumigatus Cu,Zn superoxide dismutase.

Authors:  M D Holdom; R J Hay; A J Hamilton
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection.

Authors:  Esmaeil Mortaz; Somayeh Sarhifynia; Majid Marjani; Afshin Moniri; Davood Mansouri; Payam Mehrian; Karin van Leeuwen; Dirk Roos; Johan Garssen; Ian M Adcock; Payam Tabarsi
Journal:  BMC Infect Dis       Date:  2018-11-08       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.